Corrigendum to “Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways”

Wang T, Cheng M, Jin J, et al. Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways. J Int Med Res 2024; 52(3). doi:10.1177/03000605241234567

In the article, an incorrect version of Figure 2(d) was mistakenly included.

The correct Figure 2 is as follows:

Figure 2.

LncRNA H19 accelerated b-glycerophosphate (b-GP)-induced vascular smooth muscle cell (VSMC) osteoblastic differentiation and calcification. (a) Transfection efficiency of shRNA H19 in VSMCs. (b) Calcium content, (c) alkaline phosphatase activity, and (d) Alizarin Red S staining in VSMCs infected with shRNA H19 compared with that in control VSMCs. (e–f) Quantitative reverse transcription polymerase chain reaction analysis of Runx2 and SM22a in shRNA H19-infected VSMCs compared with that in control VSMCs. *p < 0.05 and (g) Western blotting images and quantification data of Runx2 and SM22a protein levels in different groups. *p < 0.05. The arrows indicate calcified nodules.